Zhuhai, Guangdong, China Livzon Pharmaceutical Group appeared to be the Corporate Investor, which was created in 1985. The main office of represented Corporate Investor is situated in the Zhuhai. The fund was located in Asia if to be more exact in China.
Among the most popular fund investment industries, there are Medical, Health Diagnostics. For fund there is no match between the location of its establishment and the land of its numerous investments - United States. The fund has no specific favorite in a number of founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight Elicio Therapeutics, Cynvenio Biosystems. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund.
The standard case for the fund is to invest in rounds with 2-3 partakers. The meaningful sponsors for the fund in investment in the same round are Syno Capital, Greenwoods Asset Management, EFung Capital.
The important activity for fund was in 2015. Considering the real fund results, this Corporate Investor is 47 percentage points more often commits exit comparing to other organizations. The usual things for fund are deals in the range of 10 - 50 millions dollars. The fund is generally included in less than 2 deals every year.
Related Funds
| Fund Name | Location |
| Alfa Ventures | Delhi, Delhi, India |
| Almeda Ventures | Israel, Tel Aviv, Tel Aviv District |
| Ann Arbor Angels | Ann Arbor, Michigan, United States |
| DoubleLine Equity Healthcare Fund | - |
| Huihua Investment | China, Fenghua, Zhejiang |
| Korea Thrunet Co | Seoul, Seoul-t'ukpyolsi, South Korea |
| Lan Fund | Beijing, Beijing, China |
| Lianhe Zhongan Wenhua | Beijing, China, Haidian |
| Milestone Capital Partners | England, London, United Kingdom |
| Qianshan Capital | Chaoyang, China, Liaoning |
| Qicheng Chuang Tou | China, Dongguan, Hebei |
| Quintus Vermoegensverwaltung GmbH | - |
| Resolute Ventures | California, San Francisco, United States |
| Saracen Ventures | - |
| Shenzhen Shi Qianhai Dingdian Jinrong | China, Guangdong, Shenzhen |
| Startup:Education | New Jersey, Newark, United States |
| Stokke Industri | - |
| Thurston Group | Chicago, Illinois, United States |
| Viscogliosi Brothers | New York, New York, United States |
| Westcott LLC | Dallas, Texas, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Carisma Therapeutics | $30M | 21 Sep 2022 | Philadelphia, Pennsylvania, United States | ||
Atom Bioscience & Pharmaceutical | $45M | 05 Jan 2022 | Zhenjiang, Guangdong Province, China | ||
Carisma Therapeutics | $12M | 01 Mar 2021 | Philadelphia, Pennsylvania, United States | ||
Carisma Therapeutics | $47M | 07 Jan 2021 | Philadelphia, Pennsylvania, United States | ||
Atom Bioscience & Pharmaceutical | $30M | 27 May 2020 | Guangdong Province | ||
Elicio Therapeutics | $33M | 02 Oct 2019 | Cambridge, Massachusetts, United States | ||
St Phi Therapeutics | 01 Jun 2019 | Shanghai, Shanghai, China | |||
Livzon Mabpharm | 27 Jun 2018 | Xiangzhou District, Guangdong Province, China | |||
LungLife AI | $25M | 17 Jun 2015 | California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Carisma Therapeutics | $30M | 21 Sep 2022 | Philadelphia, Pennsylvania, United States | ||
Atom Bioscience & Pharmaceutical | $45M | 05 Jan 2022 | Zhenjiang, Guangdong Province, China | ||
Carisma Therapeutics | $12M | 01 Mar 2021 | Philadelphia, Pennsylvania, United States | ||
Carisma Therapeutics | $47M | 07 Jan 2021 | Philadelphia, Pennsylvania, United States | ||
Atom Bioscience & Pharmaceutical | $30M | 27 May 2020 | Guangdong Province | ||
Elicio Therapeutics | $33M | 02 Oct 2019 | Cambridge, Massachusetts, United States | ||
St Phi Therapeutics | 01 Jun 2019 | Shanghai, Shanghai, China | |||
Livzon Mabpharm | 27 Jun 2018 | Xiangzhou District, Guangdong Province, China | |||
LungLife AI | $25M | 17 Jun 2015 | California, United States |
